Home
Immediapress
Pr Newswire
Comunicato stampa - contenuto promozionale
Responsabilità editoriale PrNewswire
HOUSTON, May 28, 2026 /PRNewswire/ -- Sino Biological, Inc. (Shenzhen Stock Exchange: 301047.SZ) has announced that its gene synthesis and cell-free protein expression workflow was used in a recent study by Tencent AI for Life Sciences Lab published in Nature Communications,
Home
Immediapress
Pr Newswire
Comunicato stampa - contenuto promozionale
Responsabilità editoriale PrNewswire

Small biotech firms quicker to 'latch onto' AI than big ones, says Tencent Healthcare President

SynuSight-Shanghai Jiao Tong University Collaboration Published in Cell, Advancing Diagnostic Classification of Synucleinopathies

Biocytogen lancia la piattaforma basata sull'IA RenSuper™ e la prima infrastruttura per la scoperta di anticorpi totalmente automatizzata del settore

Tutte le Big Pharma che investono nell'IA - Startmag

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

China’s efforts to combine artificial intelligence with biotechnology are moving from computer models to laboratory experiments,…

GenScript and Tamarind Bio Partner to Connect AI Molecular Design with Rapid Lab Validation

Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio

A boom in GLP-1s and health care costs, AI-designed hair growth drugs, and more biotech news from The Readout

HONG KONG, May 28 : Small biotech firms "latch onto" AI more quickly than bigger firms, the head of Chinese tech giant Tencent's…

HKEY-AI2Vivo™ 1.0: HKeyBio Accelerates In Vivo Translation for AI-Designed Candidates